1.28
price up icon4.07%   0.05
pre-market  Vorhandelsmarkt:  1.31   0.03   +2.34%
loading
Schlusskurs vom Vortag:
$1.23
Offen:
$1.2
24-Stunden-Volumen:
8.72M
Relative Volume:
0.84
Marktkapitalisierung:
$815.25M
Einnahmen:
$29.48M
Nettoeinkommen (Verlust:
$-201.19M
KGV:
-4.00
EPS:
-0.32
Netto-Cashflow:
$-216.50M
1W Leistung:
+1.59%
1M Leistung:
-15.23%
6M Leistung:
-57.19%
1J Leistung:
-72.65%
1-Tages-Spanne:
Value
$1.20
$1.31
1-Wochen-Bereich:
Value
$1.20
$1.335
52-Wochen-Spanne:
Value
$1.17
$4.89

Geron Corp Stock (GERN) Company Profile

Name
Firmenname
Geron Corp
Name
Telefon
(650) 473-7700
Name
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Name
Mitarbeiter
229
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
GERN's Discussions on Twitter

Vergleichen Sie GERN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GERN
Geron Corp
1.28 802.52M 29.48M -201.19M -216.50M -0.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Geron Corp Stock (GERN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-10 Fortgesetzt Goldman Sell
2025-05-08 Herabstufung Scotiabank Sector Outperform → Sector Perform
2025-02-27 Herabstufung B. Riley Securities Buy → Neutral
2025-02-26 Herabstufung H.C. Wainwright Buy → Neutral
2024-11-05 Eingeleitet H.C. Wainwright Buy
2024-10-16 Eingeleitet Scotiabank Sector Outperform
2024-09-09 Eingeleitet Leerink Partners Outperform
2024-04-30 Herabstufung Robert W. Baird Outperform → Neutral
2024-04-29 Eingeleitet TD Cowen Buy
2024-03-15 Bestätigt Needham Buy
2023-09-12 Hochstufung Goldman Neutral → Buy
2023-03-28 Eingeleitet Goldman Neutral
2022-10-28 Eingeleitet Wedbush Outperform
2022-07-28 Fortgesetzt B. Riley Securities Buy
2021-11-02 Eingeleitet Robert W. Baird Outperform
2021-02-18 Fortgesetzt B. Riley Securities Buy
2020-08-03 Eingeleitet Stifel Buy
2019-11-19 Fortgesetzt B. Riley FBR Buy
2019-09-03 Eingeleitet H.C. Wainwright Buy
2019-08-15 Eingeleitet Cantor Fitzgerald Overweight
2019-04-09 Hochstufung Needham Hold → Buy
2019-01-31 Hochstufung B. Riley FBR Neutral → Buy
2018-10-02 Herabstufung B. Riley FBR Buy → Neutral
2018-07-05 Eingeleitet B. Riley FBR, Inc. Buy
2016-09-13 Bestätigt FBR & Co. Outperform
2016-09-13 Bestätigt FBR Capital Outperform
2015-12-07 Bestätigt Piper Jaffray Overweight
2015-04-21 Eingeleitet Oppenheimer Outperform
2014-06-12 Hochstufung MLV & Co Hold → Buy
2014-03-12 Herabstufung MLV & Co Buy → Hold
2013-12-10 Bestätigt MLV & Co Buy
2013-12-10 Hochstufung Needham Hold → Buy
2013-11-08 Bestätigt MLV & Co Buy
2013-10-16 Eingeleitet MLV & Co Buy
2012-08-30 Eingeleitet Stifel Nicolaus Buy
2012-06-28 Eingeleitet Needham Hold
Alle ansehen

Geron Corp Aktie (GERN) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Geron Corporation stockOutstanding stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Market Sentiment Around Loss-Making Geron Corporation (NASDAQ:GERN) - simplywall.st

Jul 20, 2025
pulisher
Jul 19, 2025

Geron Corporation Stock Analysis and ForecastOutstanding capital returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Geron Corporation (GERN) Plunges 3.88% to 2025 Low on Earnings Miss - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Commercial Stage Biotech Geron Expands Team with 342,000 Share Equity Package for Strategic New Hires - Stock Titan

Jul 18, 2025
pulisher
Jul 15, 2025

Why Geron Corporation stock attracts strong analyst attentionTechnical Breakout List - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Geron Corporation stock price move sharplyTriple Return With Stability - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Geron Presents Positive RYTELO Data for LR-MDS at ASCO & EHA, Highlights Efficacy, Myelofibrosis Program Progress - Insider Monkey

Jul 15, 2025
pulisher
Jul 15, 2025

Geron Corporation (NASDAQ:GERN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Jul 15, 2025
pulisher
Jul 13, 2025

Geron (NASDAQ:GERN) Shares Gap Down – Here’s Why - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Cambridge Investment Research Advisors Inc. Cuts Stock Position in Geron Corporation (NASDAQ:GERN) - Defense World

Jul 13, 2025
pulisher
Jul 12, 2025

Here’s Why Geron Corp. (NASDAQ:GERN) Crashed Today - MSN

Jul 12, 2025
pulisher
Jul 10, 2025

Geron resumed with a Sell at Goldman Sachs - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

Geron Corp’s Rytelo Faces Market Challenges and Declining Physician Adoption, Supporting Sell Rating - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

Goldman Sachs resumes Geron stock coverage with Sell rating on weak Rytelo sales - Investing.com

Jul 10, 2025
pulisher
Jul 08, 2025

Geron Corp (GERN) Stock: A Year of Highs and Lows - investchronicle.com

Jul 08, 2025
pulisher
Jul 07, 2025

Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) - MSN

Jul 07, 2025
pulisher
Jul 06, 2025

13 Stocks Under $5 With High Upside Potential - Insider Monkey

Jul 06, 2025
pulisher
Jul 01, 2025

DSS switches auditors to HTL; no disputes with Grassi reported | GERN SEC FilingForm 4 - Stock Titan

Jul 01, 2025
pulisher
Jun 30, 2025

Geron Corporation(NasdaqGS: GERN) dropped from Russell 2500 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Geron Corporation(NasdaqGS: GERN) dropped from Russell Small Cap Comp Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 18, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Geron Expands Team with 16 New Hires, Awards Over $1.6M in Stock Options and RSUs - Stock Titan

Jun 18, 2025
pulisher
Jun 13, 2025

With 65% institutional ownership, Geron Corporation (NASDAQ:GERN) is a favorite amongst the big guns - Yahoo Finance

Jun 13, 2025
pulisher
Jun 11, 2025

Geron: A Tough First Year For Rytelo, But Not Yet Time To Sell (Downgrade) (NASDAQ:GERN) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 10, 2025

Favourable Signals For Geron: Numerous Insiders Acquired Stock - simplywall.st

Jun 10, 2025
pulisher
Jun 09, 2025

Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges By Investing.com - Investing.com Canada

Jun 09, 2025
pulisher
Jun 06, 2025

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

Class Action Filed Against Geron Corporation (GERN)May 12, 2025 Deadline to JoinContact The Gross Law Firm - mx.advfn.com

Jun 06, 2025
pulisher
Jun 03, 2025

Conservative Vision Of A Positive Future For Geron (NASDAQ:GERN) - Seeking Alpha

Jun 03, 2025
pulisher
Jun 03, 2025

Is Geron Corporation Stock a Bargain Now? - StocksToTrade

Jun 03, 2025
pulisher
May 30, 2025

Nuveen Asset Management LLC Purchases 14,657 Shares of Geron Co. (NASDAQ:GERN) - Defense World

May 30, 2025
pulisher
May 29, 2025

Geron showcases RYTELO benefits at oncology meetings By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Geron’s SWOT analysis: oncology firm’s stock faces growth hurdles By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 28, 2025

Geron showcases RYTELO benefits at oncology meetings - Investing.com

May 28, 2025
pulisher
May 28, 2025

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program - Yahoo Finance

May 28, 2025
pulisher
May 28, 2025

Geron’s SWOT analysis: oncology firm’s stock faces growth hurdles - Investing.com

May 28, 2025
pulisher
May 27, 2025

Geron Corp stockholders approve equity plan amendments By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Geron Corp stockholders approve equity plan amendments - Investing.com

May 27, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Decreases Stock Holdings in Geron Co. (NASDAQ:GERN) - Defense World

May 27, 2025
pulisher
May 26, 2025

25,148 Shares in Geron Co. (NASDAQ:GERN) Purchased by Lazard Asset Management LLC - Defense World

May 26, 2025
pulisher
May 26, 2025

Geron Co. (NASDAQ:GERN) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

May 26, 2025
pulisher
May 22, 2025

Bank of America Corp DE Boosts Stock Position in Geron Co. (NASDAQ:GERN) - Defense World

May 22, 2025
pulisher
May 20, 2025

Ameriprise Financial Inc. Buys 247,018 Shares of Geron Co. (NASDAQ:GERN) - Defense World

May 20, 2025
pulisher
May 19, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GERN Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Geron Grants $522K Worth of Stock Options and RSUs: New Employee Compensation Details Revealed - Stock Titan

May 19, 2025
pulisher
May 16, 2025

Stifel Financial Corp Increases Position in Geron Co. (NASDAQ:GERN) - Defense World

May 16, 2025
pulisher
May 15, 2025

Geron Corp Stock (GERN): Demand Recovery on the Rise - Value The Markets

May 15, 2025
pulisher
May 14, 2025

Northern Trust Corp Has $19.76 Million Stake in Geron Co. (NASDAQ:GERN) - Defense World

May 14, 2025
pulisher
May 13, 2025

Why Geron Corporation (GERN) Is The Best Low Priced Biotech Stock to Buy Now - Insider Monkey

May 13, 2025

Finanzdaten der Geron Corp-Aktie (GERN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):